ACI
NPTN

AMP Capital Investors’s NEOPHOTONICS CORP NPTN Stock Holding History

AMP Capital Investors’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-26,200
Closed -$296K – 1254
2015
Q4 		$296K Buy
+26,200
New +$237K ﹤0.01% 1077

Other funds holding NPTN

OMC
Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

AMP Capital Investors's NPTN Position: Q1 2016 in Review

AMP Capital Investors sold out of NEOPHOTONICS CORP (NPTN) in Q1 2016, closing a stake of 26,200 shares — an estimated $296K sold.

AMP Capital Investors first reported a position in NPTN in Q4 2015 and held it in 1 quarter. The position peaked at $296K in Q4 2015. 132 funds tracked by Wall St. Rank hold NPTN as of Q1 2016.

  • AMP Capital Investors reported no remaining NEOPHOTONICS CORP position as of Q1 2016 after selling out during the quarter.
  • AMP Capital Investors sold 26,200 NEOPHOTONICS CORP shares in Q1 2016, an estimated $296K.
  • AMP Capital Investors first reported a position in NEOPHOTONICS CORP in Q4 2015 and held it in 1 quarter.
  • AMP Capital Investors's NEOPHOTONICS CORP position peaked at $296K in Q4 2015.
  • 132 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2016.

Based on AMP Capital Investors's 13F filing for Q1 2016, filed 16 May 2016.